These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 17469317

  • 1. [Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain].
    Bijlsma JW, Lems WF, van de Laar MA.
    Ned Tijdschr Geneeskd; 2007 Apr 07; 151(14):795-8. PubMed ID: 17469317
    [Abstract] [Full Text] [Related]

  • 2. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire Int; 2007 Dec 07; 16(92):223-7. PubMed ID: 18084859
    [Abstract] [Full Text] [Related]

  • 3. The use of NSAIDs in rheumatic disorders 2005: a global perspective.
    Kean WF, Buchanan WW.
    Inflammopharmacology; 2005 Dec 07; 13(4):343-70. PubMed ID: 16354389
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF, Hsiao FY, Wen YW, Tsai YW.
    Clin Ther; 2006 Nov 07; 28(11):1827-36. PubMed ID: 17213003
    [Abstract] [Full Text] [Related]

  • 5. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs.
    van der Linden MW, van der Bij S, Welsing P, Kuipers EJ, Herings RM.
    Ann Rheum Dis; 2009 May 07; 68(5):668-73. PubMed ID: 18495734
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs].
    van den Bemt BJ, Benraad HB, Rasker JJ.
    Ned Tijdschr Geneeskd; 2007 May 12; 151(19):1062-7. PubMed ID: 17552414
    [Abstract] [Full Text] [Related]

  • 8. Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?
    Hersh EV, Lally ET, Moore PA.
    Curr Med Res Opin; 2005 Aug 12; 21(8):1217-26. PubMed ID: 16083531
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal.
    Hinz B, Renner B, Brune K.
    Nat Clin Pract Rheumatol; 2007 Oct 12; 3(10):552-60; quiz 1 p following 589. PubMed ID: 17906610
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.
    Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ.
    Pharmacoepidemiol Drug Saf; 2006 Dec 12; 15(12):861-72. PubMed ID: 17086563
    [Abstract] [Full Text] [Related]

  • 15. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
    Strand V.
    Lancet; 2007 Dec 22; 370(9605):2138-51. PubMed ID: 18156036
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.